The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira) - Trial UMIN000051180
Access comprehensive clinical trial information for UMIN000051180 through Pure Global AI's free database. This phase not specified trial is sponsored by Edogawa Hospital and is currently Completed. The study focuses on Type 2 diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000051180
Completed
Trial Details
University Hospital Medical Information Network • UMIN000051180
The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira)
Study Focus
Observational
Sponsor & Location
Edogawa Hospital
Japan
Timeline & Enrollment
N/A
Dec 01, 2020
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
University Hospital Medical Information Network
UMIN000051180
Non-Device Trial